You watched
Dear buyers! Unfortunately, we are currently unable to accept the application to Canada and are revoking the license. Keep an eye on the site to see if there are any updates from Canada.
Catalog
Client
Currency:
Contacts
Our location:
Ternopil city
Contacts
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
2
Wishlist
0
Compare
0
Contacts

Depos suspension for injection 7mg/1ml syringe 1ml No. 1

SKU: an-1062242
0
All about product
Description
Specification
Reviews 0
Questions0
new
Depos suspension for injection 7mg/1ml syringe 1ml No. 1
Depos suspension for injection 7mg/1ml syringe 1ml No. 1
Depos suspension for injection 7mg/1ml syringe 1ml No. 1
Depos suspension for injection 7mg/1ml syringe 1ml No. 1
In Stock
502.40 грн.
Active ingredient:Betamethasone
Adults:Can
Country of manufacture:Ukraine
Diabetics:With caution
Dosage:7 mg/ml
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Depos suspension for injection 7mg/1ml syringe 1ml No. 1
502.40 грн.
Description

Depot - is a combination of soluble and sparingly soluble betamethasone esters for intramuscular, intraarticular, periarticular, intrasynovial and intradermal injections, as well as for administration directly to the lesion. Depot has high glucocorticosteroid activity and insignificant mineralocorticosteroid activity.

Indications for use

dermatological diseases: atopic dermatitis, neurodermatitis, contact dermatitis, severe solar dermatitis; rheumatic conditions: rheumatoid arthritis, osteoarthritis, bursitis, tendosynovitis, tendonitis; collagen diseases: systemic lupus erythematosus, scleroderma; oncological diseases: palliative therapy of leukemia and lymphoma in adults, acute leukemia in children.

Warehouse

1 ml of suspension contains 6.43 mg of micronized betamethasone dipropionate in terms of 100% dry matter (equivalent to 5 mg of betamethasone), 2.63 mg of betamethasone sodium phosphate in terms of 100% anhydrous matter (equivalent to 2 mg of betamethasone); excipients: methylparaben (E 218), propylparaben (E 216), benzyl alcohol, sodium chloride, anhydrous sodium hydrogen phosphate, disodium edetate, sodium carboxymethylcellulose, polysorbate 80, polyethylene glycol 4000, water for injections.

Contraindication

Hypersensitivity to betamethasone, other components of the drug or to other glucocorticosteroids. Systemic mycoses. Intramuscular administration in patients with idiopathic thrombocytopenic purpura.

Method of application

Systemic application

The initial dose of the drug in most cases is 1-2 ml. The injection is repeated if necessary, depending on the patient's condition. The drug is administered deep intramuscularly into the buttock.

Topical application

In acute bursitis, injecting 1-2 ml of Depo into the bursa can relieve pain and restore full mobility within a few hours.

In rheumatoid arthritis and osteoarthritis, intra-articular administration of the drug in a dose of 0.5-2 ml reduces pain, tenderness, and stiffness of the joints within 2-4 hours after administration. The duration of the therapeutic effect of the drug varies significantly and can be 4 weeks or more.

Application features

Serious neurological events, some of which were fatal, have been reported following epidural corticosteroid injection. Other events have included reports of spinal cord infarction, paraplegia, quadriplegia, cortical blindness, and stroke. These serious neurological events have occurred with and without the use of fluoroscopy.

Pregnant women

Due to the lack of controlled studies on the safety of the drug, pregnant women, breastfeeding women, and women of reproductive age should be prescribed the drug after careful assessment of the benefit to the mother and the potential risk to the fetus/child.

Children

There is insufficient clinical data on the use of the drug in children, therefore it is undesirable to use it in patients of this age category (possible growth retardation and development of secondary adrenal insufficiency).

Drivers

It is recommended to refrain from driving or operating other mechanisms during treatment with the drug.

Overdose

Administration of high doses of glucocorticosteroids for several days does not lead to undesirable effects (except in cases of very high doses or in cases of use in diabetes mellitus, glaucoma, exacerbation of erosive-ulcerative lesions of the gastrointestinal tract, in cases of use in patients who are simultaneously undergoing therapy with cardiac glycosides, indirect anticoagulants or potassium-sparing diuretics).

Side effects

Disturbances of water and electrolyte balance: natriemia, increased potassium excretion, hypokalemic alkalosis, increased calcium excretion.

Cardiovascular system: congestive heart failure in patients predisposed to this disease; arterial hypertension.

On the part of the digestive system: hiccups, erosive-ulcerative lesions of the stomach with possible perforation and bleeding, esophageal ulcers, pancreatitis, flatulence, intestinal perforation, nausea, vomiting.

Storage conditions

Store in the original packaging at a temperature not exceeding 25°C. Do not freeze. Keep out of the reach of children.

Specifications
Characteristics
Active ingredient
Betamethasone
Adults
Can
Country of manufacture
Ukraine
Diabetics
With caution
Dosage
7 mg/ml
Drivers
With caution
For allergies
With caution
For children
It is impossible.
Form
Pre-filled syringes
Method of application
Long-acting injections
Nursing
It is impossible.
Pregnant
It is impossible.
Producer
Farmak JSC
Quantity per package
1 syringe
Trade name
Depot
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Pompezo lyophilisate for solution for injection 40 mg No. 1
In stock
0
467.69 грн.